Omar Minai, MD

216.444.6503

Omar Minai, MD

Appointed: 1999

Omar Minai, MD
Department: Pulmonary Medicine
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
DeskDesk:216.445.2610
WorkFax:216.445.6024
Omar Minai, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
DeskDesk:216.445.2610
WorkFax:216.445.6024
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Omar A. Minai, MD, FCCP, DABSM, is a Staff Physician in the Department of Pulmonary, Allergy, and Critical Care Medicine and the Lung Transplant Center at Cleveland Clinic.

Dr. Minai’s main clinical and research interests include pulmonary hypertension, advanced COPD, sleep disorders and lung transplantation. He has authored or co-authored more than 30 publications primarily related to advanced lung diseases such as pulmonary arterial hypertension, emphysema, and lung transplantation.

He obtained his medical degree from the Aga Khan University in Karachi, Pakistan in 1990. He completed a residency in internal medicine at the University of Connecticut, and he was a Chief Resident. Dr. Minai completed his Pulmonary, Critical care, and Sleep Medicine training at the Cleveland Clinic in 1999, when he joined the faculty in the Department of Pulmonary, Allergy, and Critical Care Medicine.

Dr. Minai is board-certified in the fields of pulmonary medicine, critical care medicine and sleep medicine. He is a Fellow of the American College of Chest Physicians and a member of the American Thoracic Society and the American Academy of Sleep Medicine.

Professional Highlights

  • Elected Fellow of the American College of Chest Physicians

Education & Fellowships

Fellowship - Cleveland Clinic
Pulmonary & Critical Care
Cleveland, OH USA
1999
Residency - University of Connecticut Health Center/John Dempsey Hospital
Internal Medicine
Farmington, CT USA
1996
Internship - University of Connecticut Health Center/John Dempsey Hospital
Internal Medicine
Farmington, CT USA
1993
Medical School - The Aga Khan University Faculty of Health Sciences
Karachi Pakistan
1990

Certifications

  • Internal Medicine- Pulmonary Disease
  • Internal Medicine- Critical Care Medicine
  • Internal Medicine- Sleep Medicine

Specialty Interests

Chronic obstructive pulmonary disease (COPD), hypersensitivity pneumonitis, langerhans cell histiocytosis (LCH), lung cancer, lymphangioleiomyomatosis (LAM), pulmonary fibrosis, pulmonary hypertension, respiratory syncytial virus (RSV), sleep apnea, sleep disorders

Awards & Honors

  • Recognized as one of America's Top Doctors by the Consumer Research Council of America, 2007
  • Included in the Global Registry of Who's Who
  • Included in the Marquis Who's Who in America

Memberships

  • Pulmonary Hypertension Association
  • American Association of Sleep Medicine
  • American Thoracic Society
  • American College of Chest Physicians

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/7/2014, Dr. Minai has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Minai receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Forest Pharmaceuticals
  • GlaxoSmithKline plc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Urdu
Cleveland Clinic Mobile Site